Imugene Ltd logo

Imugene Ltd

NEW
OTCPK:IUGNF (Australia)  
$ 0.024 -0.0030 (-11.11%) 08:09 PM EST
At Loss
P/B:
2.40
Market Cap:
$ 169.65M
Enterprise V:
$ 161.84M
Volume:
631.02K
Avg Vol (2M):
129.15K
Trade In:
Volume:
631.02K
At Loss
Avg Vol (2M):
129.15K

Business Description

Description
Imugene Ltd specializes in a clinical-stage immuno-oncology company. Its products include HER-Vaxx, PD1-Vaxx, CF33 and CF33 CD19. HER-Vaxx is a proprietary HER2 +ve cancer vaccine that stimulates a polyclonal antibody response to HER2/neu. The company is also developing B-cell peptide cancer vaccines and therapeutics. Its only operating segment is the Research and Development of oncolytic immunotherapies.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 2.4
Equity-to-Asset 0.52
Debt-to-Equity 0.23
Debt-to-EBITDA -0.12
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 44.56
9-Day RSI 47.12
14-Day RSI 48.25
3-1 Month Momentum % 1.61
6-1 Month Momentum % -36.95
12-1 Month Momentum % -68.06

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.08
Quick Ratio 3.08
Cash Ratio 1.33

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -13.8
Shareholder Yield % -2.89

Profitability Rank

Name Current Vs Industry Vs History
ROE % -103.07
ROA % -77.16
ROIC % -161.34
3-Year ROIIC % -638.72
ROC (Joel Greenblatt) % -739.09
ROCE % -90.14

Financials

IUGNF's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:IUGNF

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016

Imugene Ltd Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -0.011
Beta 2.88
3-Year Sharpe Ratio -0.3
3-Year Sortino Ratio -0.6
Volatility % 51.57
14-Day RSI 48.25
14-Day ATR ($) 0.004652
20-Day SMA ($) 0.02665
12-1 Month Momentum % -68.06
52-Week Range ($) 0.0044 - 0.105
Shares Outstanding (Mil) 7,576.29

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 1
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Imugene Ltd Filings

Filing Date Document Date Form
No Filing Data

Imugene Ltd Stock Events

Financials Calendars
Event Date Price ($)
No Event Data

Imugene Ltd Frequently Asked Questions

What is Imugene Ltd(IUGNF)'s stock price today?
The current price of IUGNF is $0.02. The 52 week high of IUGNF is $0.11 and 52 week low is $0.00.
When is next earnings date of Imugene Ltd(IUGNF)?
The next earnings date of Imugene Ltd(IUGNF) is .
Does Imugene Ltd(IUGNF) pay dividends? If so, how much?
Imugene Ltd(IUGNF) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1